首站-论文投稿智能助手
典型文献
Bufalin Induces Programmed Necroptosis in Triple-Negative Breast Cancer Drug-Resistant Cell Lines through RIP1/ROS-Mediated Pathway
文献摘要:
Objective:To explore the effect and mechanism of action of bufalin in triple-negative breast cancer(TNBC)drug-resistant cell lines.Methods:The normal human mammary epithelial cell line,TNBC cell line,TNBC adriamycin-resistant cell line,and TNBC docetaxel-resistant cell line were treated with different doses of bufalin(0-1,000 nmol/L)at different time points(0-72 h).Propidium iodide staining,AV-FITC/PI double staining,Hoechst 33342/PI double staining and transmission electron microscopy(TEM)were used to evaluate the death patterns of the cell lines.Results:Bufalin killed the TNBC cell line and its drug-resistant cell lines in a dose/time-dependent manner(all P<0.01).After treatment with bufalin for 24 h,the adriamycin-resistant cell line showed a co-existing pattern of necroptosis and apoptosis.However,at 48 h,necroptosis was the main manifestation.After treatment with bufalin,the expressions of tumor necrosis factor α,phospho-tumor necrosis factor receptor 1,phospho-receptor interacting protein 1 and c-caspase 3 increased(all P<0.01),the killing effect of bufalin could be mostly inhibited by NEC-1,and by z-VAD-fmk(both P<0.01).Besides,the intracellular reactive oxygen species(ROS)levels increased considerably(P<0.01),the antioxidant N-acetyl cysteine or Nec-1 could inhibit the increase of ROS level and the killing effect of bufalin(all P<0.01).The adriamycin-resistant cell line exhibited necroptosis characteristic after 48 h of bufalin treatment under TEM.Conclusions:Bufalin could induce necroptosis through RIP1/ROS-mediated pathway to kill the drug-resistant TNBC cell lines.This finding provides critical experimental data and theoretical basis for the clinical application of bufalin to overcome the difficulties in the treatment of TNBC.
文献关键词:
作者姓名:
LIU Xiao-dan;SONG Cheng-yang;KONG Cui-cui;TIAN Xin
作者机构:
Department of Breast Surgery,the Fourth Affiliated Hospital of China Medical University,Shenyang 110032,China;Department of Thoracic Surgery,the Fourth Affiliated Hospital of China Medical University,Shenyang 110032,China;Molecular Oncology Laboratory of Cancer Research Institute,the First Affiliated Hospital of China Medical University,Shenyang 110001,China
引用格式:
[1]LIU Xiao-dan;SONG Cheng-yang;KONG Cui-cui;TIAN Xin-.Bufalin Induces Programmed Necroptosis in Triple-Negative Breast Cancer Drug-Resistant Cell Lines through RIP1/ROS-Mediated Pathway)[J].中国结合医学杂志(英文版),2022(10):900-908
A类:
Propidium
B类:
Bufalin,Induces,Programmed,Necroptosis,Triple,Negative,Breast,Cancer,Drug,Resistant,Cell,Lines,through,RIP1,ROS,Mediated,Pathway,Objective,To,explore,effect,mechanism,action,bufalin,triple,negative,breast,cancer,TNBC,drug,resistant,lines,Methods,normal,human,mammary,epithelial,adriamycin,docetaxel,were,treated,different,doses,nmol,points,iodide,staining,AV,FITC,double,Hoechst,transmission,electron,microscopy,TEM,used,evaluate,death,patterns,Results,killed,its,dependent,manner,all,After,treatment,showed,existing,necroptosis,apoptosis,However,was,main,manifestation,expressions,tumor,necrosis,phospho,receptor,interacting,protein,caspase,increased,killing,could,be,mostly,inhibited,by,NEC,VAD,fmk,both,Besides,intracellular,reactive,oxygen,species,levels,considerably,antioxidant,acetyl,cysteine,exhibited,characteristic,after,under,Conclusions,induce,mediated,pathway,This,finding,provides,critical,experimental,data,theoretical,basis,clinical,application,overcome,difficulties
AB值:
0.5245
相似文献
Exosomal miR-485-3p derived from pancreatic ductal epithelial cells inhibits pancreatic cancer metastasis through targeting PAK1
Li Mingzhe;Zhou Jiaxin;Zhang Zhengkui;Li Jisong;Wang Feng;Ma Ling;Tian Xiaodong;Mao Zebin;Yang Yinmo-Department of General Surgery, Peking University First Hospital, Beijing 100034, China;Department of Urology, Sir Run Run Shaw Hospital, Zhejiang University, Hangzhou, Zhejiang 310016, China;Department of Gastrointestinal Surgery, Sichuan Academy of Medical Sciences & Sichuan Provincial People’s Hospital, Chengdu, Sichuan 610072, China;Department of Surgical Oncology, Peking University Ninth School of Clinical Medicine (Beijing Shijitan Hospital, Capital Medical University), Beijing 100038, China;Department of Medical Biochemistry and Molecular Biology, Peking University Health Science Center, Beijing 100191, China
Taxifolin attenuates inflammation via suppressing MAPK signal pathway in vitro and in silico analysis
Xingyan Zhang;Xiaoyan Lian;Huling Li;Wenjing Zhao;Xin Li;Fujun Zhou;Yutong Zhou;Tao Cui;Yuli Wang;Changxiao Liu-Key Laboratory of Quality-marker of Traditional Chinese Medicines,Tianjin Institute of Pharmaceutical Research Co.,Ltd.,Tianjin 300462,China;Center for Drug Evaluation,National Medical Products Administration,Beijing 100022,China;Department of Pharmacology,Tianjin Medical University,Tianjin 300070,China;State Key Laboratory of Drug Delivery Technology and Pharmacokinetics,Tianjin Institute of Pharmaceutical Research Co.,Ltd.,Tianjin 300462,China;Key Laboratory of Systems Bioengineering(Ministry of Education),School of Chemistry Engineering and Technology,Tianjin University,Tianjin 300072,China;Pharmaceuticai Armaceuticai DA REN TANG Group Corporation Limited Traditional Chinese Pharmacy Researchinstitute,Tianjin 300457,China;Tianjin Key Laboratory of Quality Control in Chinese Medicine,Tianjin 300457,China;Research Unit for Drug Metabolism,Chinese Academy of Medical Sciences,Beijing 100730,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。